Tag Archives: insulin inhaler

MannKind Confirms Design of Pivotal Studies

MannKind Corporation MNKD +5.33% today announced that it has confirmed with the U.S. Food and Drug Administration the design of two clinical studies that evaluate the efficacy and safety of AFREZZA(R) (insulin human [rDNA origin]), an investigational, ultra rapid-acting mealtime … Continue reading

Posted in Uncategorized | Tagged , , , | Leave a comment